White and colored grapefruit juice produce similar pharmacokinetic interactions

Pharmazie

Volumn 63, Issue 8, 2008, Pages 598-600

  Uesawa, Y ^a   Abe, M ^a   Mohri, K ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6',7' DIHYDROXYBERGAMOTTIN; BERGAMOTTIN; BERGAPTOL; CYTOCHROME P450 3A4; FUROCOUMARIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GRAPEFRUIT JUICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; JAPAN; LIVER MICROSOME; PINK GRAPEFRUIT JUICE; RED GRAPEFRUIT JUICE; WHITE GRAPEFRUIT JUICE;

BEVERAGES; CITRUS PARADISI; COLOR; CYTOCHROME P-450 CYP3A; DATA INTERPRETATION, STATISTICAL; FOOD-DRUG INTERACTIONS; HEAT; OXIDATION-REDUCTION; PHARMACOKINETICS; PSORALENS; TESTOSTERONE;

EID: 50149089776     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8550     Document Type: Article

References (15)

1. Bailey DG, Spence JD, Munoz C, Arnold JM (1991) Interaction of citrus juices with felodipine and nifedipine. Lancet 337: 268-269.
2. Dahan A, Altman H (2004) Food-drag interaction: grapefruit juice augments drug bioavailability-mechanism, extent and relevance. Eur J Clin Nutr 58: 1-9.
3. De Castro WV, Mertens-Talcott S, Rubner A, Butterweck V, Derendorf H (2006) Variation of flavonoids and furanocoumarins in grapefruit juices: a potential source of variability in grapefruit juice-drug interaction studies. J Agric Food Chem 54: 249-255.
4. Fuhr U (1998) Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Saf 18: 251-272.
5. Fukuda K, Guo L, Ohashi N, Yoshikawa M, Yamazoe Y (2000) Amounts and variation in grapefruit juice of the main components causing grape fruit-drug interaction. Journal of Chromatography B, Biomedical Sciences and Applications 741: 195-203.
6. Garcia MJ, Reinoso RF, Sánchez Navarro A, Prous JR (2003) Clinical pharmacokinetics of statins. Methods Find Exp Clin Pharmacol 25: 457-481.
7. He K, Iyer KR, Hayes RN, Sinz MW, Woolf TF, Hollenberg PF (1998) Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol 11: 252-259.
8. Kane GC, Lipsky JJ (2000) Drug-grapefruit juice interactions. Mayo Clin Proc 75: 933-942.
9. Mohri K, Uesawa Y (2001) Effects of furanocoumarin derivatives in grapefruit juice on nifedípine pharmacokinetics in rats. Pharm Res 18: 177-182.
10. Row E, Brown SA, Stachulski AV, Lennard MS (2006) Development of novel furanocoumarin dimers as potent and selective inhibitors of CYP3A4. Drag Metab Dispos 34: 324-330.
11. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, He K, Lown KS, Woster PM, Rahman A, Thummel KE, Fisher JM, Hollenberg PF, Watkins PB (1997) Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos 25: 1228-1233.
12. Uesawa Y, Mohri K (2005) Comprehensive determination of furanocoumarin derivatives in citrus juice by high performance liquid chromatography. Yakugaku Zasshi 125: 875-879.
13. Uesawa Y, Mohri K (2006a) UV-Irradiated Grapefruit Juice Loses Pharmacokinetic Interaction with Nifedipine in Rats. Biol Pharm Bull 29: 1286-1289.
14. Uesawa Y, Mohri K (2006b) The use of heat treatment to eliminate drug interactions due to grapefruit juice. Biol Pharm Bull 29: 2274-2278.
15. Uesawa Y, Mohri K (2008) Drug interaction potentials among different brands of grapefruit juice. Pharmazie 63: 144-146.